CAR T-Cell Therapy

Exa-Cel Eliminates Vaso-Occlusive Crises in Most Sickle Cell Patients

Blood Disorders

Exa-Cel Eliminates Vaso-Occlusive Crises in Most Sickle Cell Patients

Apr 25, 2024

1 min read

CD7 CAR T-Cell Therapy, Stem-Cell Transplant Beneficial for CD7-Positive Tumors

CD7 CAR T-Cell Therapy, Stem-Cell Transplant Beneficial for CD7-Positive Tumors

Apr 25, 2024

2 min read

FDA Approves Abecma for Relapsed, Refractory Multiple Myeloma

FDA Approves Abecma for Relapsed, Refractory Multiple Myeloma

Apr 09, 2024

2 min read

EEG Most Beneficial Tool for Managing CAR T-Cell-Related Neurotoxicity

Blood Disorders

EEG Most Beneficial Tool for Managing CAR T-Cell-Related Neurotoxicity

Apr 05, 2024

1 min read

CARv3-TEAM-E T-Cell Treatment Beneficial for Recurrent Glioblastoma

CARv3-TEAM-E T-Cell Treatment Beneficial for Recurrent Glioblastoma

Mar 21, 2024

1 min read

Second Primary Malignancies Represent Small Proportion of Adverse Events After CAR T-Cell Therapy

Second Primary Malignancies Represent Small Proportion of Adverse Events After CAR T-Cell Therapy

Mar 20, 2024

1 min read

FDA Approves First CAR T-Cell Therapy for Adults With Leukemia or Lymphoma

FDA Approves First CAR T-Cell Therapy for Adults With Leukemia or Lymphoma

Mar 18, 2024

2 min read

CAR T-Cell Therapy Feasible, Safe for Autoimmune Diseases

CAR T-Cell Therapy Feasible, Safe for Autoimmune Diseases

Feb 21, 2024

1 min read

Risk Stratification Can Predict Outcomes for CAR T-Cell Therapy in Lymphoma

Risk Stratification Can Predict Outcomes for CAR T-Cell Therapy in Lymphoma

Feb 15, 2024

1 min read

Read More

www.healthday.com